文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Metastasis review: from bench to bedside.

作者信息

Alizadeh Ali Mohammad, Shiri Sadaf, Farsinejad Sadaf

机构信息

Cancer Research Center, Tehran University of Medical Sciences, Tehran, 1419733141, Iran,

出版信息

Tumour Biol. 2014 Sep;35(9):8483-523. doi: 10.1007/s13277-014-2421-z. Epub 2014 Aug 8.


DOI:10.1007/s13277-014-2421-z
PMID:25104089
Abstract

Cancer is the final result of uninhibited cell growth that involves an enormous group of associated diseases. One major aspect of cancer is when cells attack adjacent components of the body and spread to other organs, named metastasis, which is the major cause of cancer-related mortality. In developing this process, metastatic cells must successfully negotiate a series of complex steps, including dissociation, invasion, intravasation, extravasation, and dormancy regulated by various signaling pathways. In this review, we will focus on the recent studies and collect a comprehensive encyclopedia in molecular basis of metastasis, and then we will discuss some new potential therapeutics which target the metastasis pathways. Understanding the new aspects on molecular mechanisms and signaling pathways controlling tumor cell metastasis is critical for the development of therapeutic strategies for cancer patients that would be valuable for researchers in both fields of molecular and clinical oncology.

摘要

相似文献

[1]
Metastasis review: from bench to bedside.

Tumour Biol. 2014-9

[2]
From bench to bedside: does preclinical practice in translational oncology need some rebuilding?

J Natl Cancer Inst. 2013-10-2

[3]
Translational oncology toward benefiting cancer patients: the Sun Yat-sen University Cancer Center experience.

Sci China Life Sci. 2016-10

[4]
Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.

Oncotarget. 2016-11-15

[5]
TGF-β signaling in cancer metastasis.

Acta Biochim Biophys Sin (Shanghai). 2018-1-1

[6]
[Targeted based therapies in metastatic breast cancer: future evolution].

Therapie. 2012

[7]
Aberrant B-Raf signaling in human cancer -- 10 years from bench to bedside.

Crit Rev Oncog. 2012

[8]
Role of myeloid-derived suppressor cells in metastasis.

Cancer Metastasis Rev. 2021-6

[9]
[Together, towards precise oncology!].

Rev Med Suisse. 2014-5-21

[10]
The metastatic process: methodological advances and pharmacological challenges.

Curr Med Chem. 2009

引用本文的文献

[1]
Molecular Mechanisms of Lymphatic Metastasis in Breast Cancer: An Updated Review.

Cancers (Basel). 2025-6-25

[2]
Particulate Matter 2.5 Induces FGFR1-mediated Integrin Switch to Promote Non-small Cell Lung Cancer Metastasis.

Cancer Genomics Proteomics. 2025-6-26

[3]
Nanosponge-Encapsulated Polyoxometalates: Unveiling the Multi-Faceted Potential Against Cancers and Metastases Through Comprehensive Preparation, Characterization, and Computational Exploration.

Pharmaceuticals (Basel). 2025-2-28

[4]
Mechanisms of GPM6A in Malignant Tumors.

Cancer Rep (Hoboken). 2025-2

[5]
ABO Blood Type and Pretreatment Systemic Inflammatory Response Index Associated with Lymph Node Metastasis in Patients with Breast Cancer.

Int J Gen Med. 2024-10-23

[6]
Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical Challenges.

ACS Nano. 2024-9-10

[7]
Assessment of structural and activity-related contributions of various PIM-1 kinase inhibitors in the treatment of leukemia and prostate cancer.

Mol Divers. 2024-4-20

[8]
Roles of Rictor alterations in gastrointestinal tumors (Review).

Oncol Rep. 2024-2

[9]
immunotherapy combined with gemcitabine has a synergistic inhibitory effect on tumor growth and metastasis in murine Lewis lung cancer models.

Front Oncol. 2023-10-17

[10]
Mechanisms and Application of Gas-Based Anticancer Therapies.

Pharmaceuticals (Basel). 2023-10-2

本文引用的文献

[1]
Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy.

Cancer Cell. 2014-6-2

[2]
Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments.

Nat Commun. 2014

[3]
V-ATPase inhibition regulates anoikis resistance and metastasis of cancer cells.

Mol Cancer Ther. 2014-4

[4]
Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration.

Mol Cancer. 2014-1-27

[5]
Global dormancy of metastases due to systemic inhibition of angiogenesis.

PLoS One. 2014-1-21

[6]
An antibody-drug conjugate that targets tissue factor exhibits potent therapeutic activity against a broad range of solid tumors.

Cancer Res. 2013-12-26

[7]
Combined SFK/MEK inhibition prevents metastatic outgrowth of dormant tumor cells.

J Clin Invest. 2013-12-9

[8]
VEGF and pleiotrophin modulate the immune profile of breast cancer.

Cancers (Basel). 2010-5-26

[9]
Integrin-free tetraspanin CD151 can inhibit tumor cell motility upon clustering and is a clinical indicator of prostate cancer progression.

Cancer Res. 2013-11-12

[10]
Physiology and pharmacology of plerixafor.

Transfus Med Hemother. 2013-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索